Search research articles
Contact Us
Filters
Showing results (181-190 of 194) with videos related to
Page
of 20
Sort By:
Frontiers in Immunology
|
November 15, 2021
Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy
Wei Chen, Yuhan Ma, Ziyuan Shen, et al.
Cytotherapy
|
April 16, 2024
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy
Hai Cheng, Yingjun Sun, Xiaoxue Zhang, et al.
Cytotherapy
|
September 16, 2024
Comprehensive characterization of cytopenia after chimeric antigen receptor-T cell infusion in patients with relapsed or refractory multiple myeloma
Hai Cheng, Lingyan Shao, Dandan Wang, et al.
American Journal of Hematology
|
July 31, 2015
MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production
Wei Sang, Cong Zhang, Dianzheng Zhang, et al.
Clinical and Experimental Medicine
|
September 4, 2024
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Ruixue Ma, Qi Zhang, Yang Liu, et al.
International Urology and Nephrology
|
May 1, 2025
Nephrotoxicity of CAR-T therapy in patients with relapsed and refractory multiple myeloma
Zihan Chen, Yegan Chen, Jiaying Liu, et al.
Clinical and Experimental Medicine
|
November 1, 2023
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy
Hai Cheng, Shengwei Ji, Jiaojiao Wang, et al.
The American Journal of Surgical Pathology
|
August 25, 2022
Clinicopathologic Features and Genomic Signature of De Novo CD5 + Diffuse Large B-Cell Lymphoma : A Multicenter Collaborative Study
Wei Sang, Yuhan Ma, Xiangmin Wang, et al.
Cancer Medicine
|
July 2, 2020
Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
Wei Sang, Ming Shi, Jingjing Yang, et al.
The New Phytologist
|
October 16, 2023
Global analysis of seed transcriptomes reveals a novel PLATZ regulator for seed size and weight control in soybean
Yang Hu, Yue Liu, Long Lu, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 194) with videos related to
Sort By:
Page
of 20
Frontiers in Immunology
|
November 15, 2021
Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy
Wei Chen, Yuhan Ma, Ziyuan Shen, et al.
Cytotherapy
|
April 16, 2024
Complex association of body mass index and outcomes in patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy
Hai Cheng, Yingjun Sun, Xiaoxue Zhang, et al.
Cytotherapy
|
September 16, 2024
Comprehensive characterization of cytopenia after chimeric antigen receptor-T cell infusion in patients with relapsed or refractory multiple myeloma
Hai Cheng, Lingyan Shao, Dandan Wang, et al.
American Journal of Hematology
|
July 31, 2015
MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production
Wei Sang, Cong Zhang, Dianzheng Zhang, et al.
Clinical and Experimental Medicine
|
September 4, 2024
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
Ruixue Ma, Qi Zhang, Yang Liu, et al.
International Urology and Nephrology
|
May 1, 2025
Nephrotoxicity of CAR-T therapy in patients with relapsed and refractory multiple myeloma
Zihan Chen, Yegan Chen, Jiaying Liu, et al.
Clinical and Experimental Medicine
|
November 1, 2023
Long-term analysis of cellular immunity in patients with RRMM treated with CAR-T cell therapy
Hai Cheng, Shengwei Ji, Jiaojiao Wang, et al.
The American Journal of Surgical Pathology
|
August 25, 2022
Clinicopathologic Features and Genomic Signature of De Novo CD5 + Diffuse Large B-Cell Lymphoma : A Multicenter Collaborative Study
Wei Sang, Yuhan Ma, Xiangmin Wang, et al.
Cancer Medicine
|
July 2, 2020
Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
Wei Sang, Ming Shi, Jingjing Yang, et al.
The New Phytologist
|
October 16, 2023
Global analysis of seed transcriptomes reveals a novel PLATZ regulator for seed size and weight control in soybean
Yang Hu, Yue Liu, Long Lu, et al.
Page
of 20